ROS-Nrf2 pathway mediates the development of TGF-β1-induced epithelial-mesenchymal transition through the activation of Notch signaling

Eur J Cell Biol. 2021 Sep-Nov;100(7-8):151181. doi: 10.1016/j.ejcb.2021.151181. Epub 2021 Nov 3.

Abstract

Epithelial-mesenchymal transition (EMT) is a cellular process by which epithelial cells transform to acquire mesenchymal phenotypes. Accumulating evidence indicate the involvement of EMT in the progression of malignant diseases. Notch signaling mediates TGF-β1-induced EMT through direct transcriptional activation of Snai1. The molecular mechanism how TGF-β1 activates Notch signaling, however, remains unknown. In this study, we show a pivotal role for reactive oxygen species (ROS)-Nrf2 pathway in TGF-β1-induced Notch signaling activation and EMT development. TGF-β1 induces Nrf2 activation through ROS production. Inhibiting Nrf2 activation either by reducing ROS levels by N-acetylcysteine or by knocking down of Nrf2 by small interfering RNA attenuated both Notch signaling activation and EMT development. TGF-β1 induced the transcription of Notch4 via Nrf2-dependent promoter activation. In conclusion, our study indicates the ROS-Nrf2 pathway mediates the development of TGF-β1-induced EMT through the activation of Notch signaling.

Keywords: A549; EMT; Notch signaling; Nrf2; ROS; TGF-β1.

Publication types

  • Review

MeSH terms

  • Epithelial-Mesenchymal Transition*
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism
  • Reactive Oxygen Species
  • Signal Transduction
  • Transforming Growth Factor beta1*

Substances

  • NF-E2-Related Factor 2
  • Reactive Oxygen Species
  • Transforming Growth Factor beta1